Conning Inc. Viatris Inc Transaction History

Conning Inc.

$2.89 Billion
Q3 2024

A detailed history of Conning Inc. transactions in Viatris Inc stock. As of the latest transaction made, Conning Inc. holds 12,452 shares of VTRS stock, worth $161,876. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,452

Previous 12,272 1.47%

Holding current value

$161,876

Previous $130,000 10.77%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$10.32 - $12.13 $1,857 - $2,183	180 Added 1.47%	12,452 $144,000
Q2 2024 Jul 26, 2024	SELL	$10.05 - $12.02 $1,899 - $2,271	-189 Reduced 1.52%	12,272 $130,000
Q2 2023 Jul 21, 2023	SELL	$9.02 - $10.29 $17,949 - $20,477	-1,990 Reduced 13.77%	12,461 $124,000
Q4 2022 Feb 07, 2023	SELL	$8.72 - $11.56 $1,037 - $1,375	-119 Reduced 0.82%	14,451 $160,000
Q3 2022 Oct 28, 2022	SELL	$8.48 - $11.13 $10,150 - $13,322	-1,197 Reduced 7.59%	14,570 $124,000
Q2 2022 Jul 20, 2022	SELL	$9.95 - $12.27 $407 - $503	-41 Reduced 0.26%	15,767 $165,000
Q1 2022 May 02, 2022	SELL	$9.81 - $15.4 $2,943 - $4,620	-300 Reduced 1.86%	15,808 $172,000
Q4 2021 Jan 27, 2022	BUY	$12.09 - $14.68 $29,016 - $35,232	2,400 Added 17.51%	16,108 $218,000
Q3 2021 Nov 05, 2021	SELL	$13.25 - $15.13 $65,892 - $75,241	-4,973 Reduced 26.62%	13,708 $186,000
Q2 2021 Jul 29, 2021	SELL	$12.97 - $16.15 $18,430 - $22,949	-1,421 Reduced 7.07%	18,681 $267,000
Q1 2021 Apr 23, 2021	SELL	$13.59 - $18.54 $20,670 - $28,199	-1,521 Reduced 7.03%	20,102 $281,000
Q4 2020 Jan 28, 2021	BUY	$14.3 - $18.74 $309,208 - $405,215	21,623 New	21,623 $405,000

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

934M

Call Options Held

2.71M

Put Options Held

2.4M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Conning Inc., based on Form 13F filings with the SEC.

News

Stay updated on Conning Inc. with notifications on news.

Account